<DOC>
	<DOCNO>NCT01915186</DOCNO>
	<brief_summary>The aim study evaluate effect DHEA supplement ovarian reserve marker , ovarian response gonadotrophin cycle outcomes patient normal poor ovarian reserve . Study Hypotheses : 1 . DHEA supplementation would improve marker ovarian reserve ovarian response low dose FSH stimulation normal poor responder 2 . DHEA supplementation would improve IVF cycle outcome</brief_summary>
	<brief_title>Use Dehydroepiandrosterone ( DHEA ) Women With Normal Poor Ovarian Reserve Undergoing IVF</brief_title>
	<detailed_description>Consecutive patient attend subfertility clinic Department Obstetrics Gynaecology , Queen Mary Hospital schedule in-vitro fertilization ( IVF ) treatment recruit write consent obtain . Baseline assessment perform early follicular phase ( Day 2 3 ) hormonal test ultrasound . Subjects divide two group , normal ovarian reserve group poor ovarian reserve group accord AFC . Poor ovarian reserve define AFC le 5 , normal ovarian reserve define AFC 5 15 base previous study show AFC good predictor ovarian response ( Tomas 1997 ) . Subjects normal ovarian reserve subdivide &lt; 35 &gt; /=35 year old subject poor ovarian reserve subdivide first subsequent cycle IVF subgroup analysis . Subjects normal poor ovarian reserve group randomize accord computer-generated randomization list seal envelope receive either DHEA 25mg three time day placebo throughout study period . Any change hormonal profile ovarian reserve assess above-mentioned blood test pelvic ultrasound scan repeat early follicle phase ( Day 2 3 ) two subsequent cycle . After two month DHEA/placebo treatment , subject give standard low dose ovarian stimulation 75 IU intramuscular human menopausal gonadotrophin ( HMG , MenogonÂ® , Ferring Pharmaceuticals ) daily 7 day . Blood test pelvic ultrasound scan repeat 7 day stimulation ( ie . day 10 11 ) . Hormonal profile ovarian reserve repeat follicular phase ( D2 3 ) subsequent cycle , patient offer cycle IVF treatment use antagonist protocol base standard departmental regimen . Cycle characteristic pregnancy outcome compare . Analysis ovarian reserve marker , ovarian response IVF outcomes would perform .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility , Female</mesh_term>
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>Indicated IVF treatment accord standard department protocol Age &lt; 40 Regular menstrual cycle ( 2135 day &lt; /= 4 day intercycle variation ) AFC 15 Previous chemotherapy pelvic irradiation Polycystic ovarian syndrome polycystic ovary On hormonal supplementation indication time recruitment ( e.g . estrogen , testosterone DHEA )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>DHEA</keyword>
	<keyword>Poor ovarian reserve</keyword>
	<keyword>Normal ovarian reserve</keyword>
	<keyword>In vitro fertilization treatment</keyword>
	<keyword>Ovarian response</keyword>
	<keyword>Pregnancy outcome</keyword>
</DOC>